Skip to menu Skip to content Skip to footer

2026

Journal Article

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study

Roos, Izanne, Sharmin, Sifat, Horakova, Dana, Kubala Havrdova, Eva, Libertinova, Jana, Vachova, Marta, Alroughani, Raed, Boz, Cavit, Rous, Zuzana, Buzzard, Katherine, Skibina, Olga, Peterka, Marek, Hradilek, Pavel, Mares, Miroslav, Coles, Alasdair, Brown, J William L, Eichau Madueño, Sara, Foschi, Matteo, Prevost, Julie, Terzi, Murat, Prat, Alexandre, Girard, Marc, Meca-Lallana, Jose E, John, Nevin, Blanco, Yolanda, van der Walt, Anneke, Butzkueven, Helmut, Recmanova, Eva, Laureys, Guy ... Kalincik, Tomas (2026). Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study. Journal of Neurology, Neurosurgery & Psychiatry, jnnp-2026. doi: 10.1136/jnnp-2026-338424

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study

2026

Journal Article

Multimodal ultra-high-field MRI, clinical, cognitive, and genetic profiles across the ALS–FTD spectrum

Shaw, Thomas B., Al Najjar, Aiman, Barth, Markus, Bollmann, Steffen, Bourgeat, Pierrick, Chang, Jeryn, Dempsey-Jones, Harriet, Fazlollahi, Amir, Fripp, Jurgen, Garden, Natalie, Guo, Christine C., Henderson, Robert D., Kuan, Elaine, Lv, Jinglei, McCombe, Pamela A., Narayanan, Aswin, Ngo, Shyuan T., Nguyen, Vinh, O’Brien, Kieran, Robinson, Gail, Robinson, Simon, Salvado, Olivier, Stewart, Ashley, Steyn, Frederik J. and Bollmann, Saskia (2026). Multimodal ultra-high-field MRI, clinical, cognitive, and genetic profiles across the ALS–FTD spectrum. Scientific Data. doi: 10.1038/s41597-026-07461-3

Multimodal ultra-high-field MRI, clinical, cognitive, and genetic profiles across the ALS–FTD spectrum

2026

Journal Article

PO 25 Applying high-density surface EMG to the study of neuromuscular disorders: a systematic review

Shandiz, Ehsan, Gaskell, Asbjorn, Mccombe, Pamela, Ingram, Matthew, Trajano, Gabriel and Henderson, Robert (2026). PO 25 Applying high-density surface EMG to the study of neuromuscular disorders: a systematic review. Clinical Neurophysiology, 185 2111038, 2111038. doi: 10.1016/j.clinph.2025.2111038

PO 25 Applying high-density surface EMG to the study of neuromuscular disorders: a systematic review

2026

Journal Article

Maximal motor unit firing rates decline with amyotrophic lateral sclerosis progression

Fernandes, Gabriel L., Orssatto, Lucas B.R., Pinto, Matheus D., Henkin, Joao S., Shandiz, Ehsan, McCombe, Pamela A., Henderson, Robert D. and Trajano, Gabriel S. (2026). Maximal motor unit firing rates decline with amyotrophic lateral sclerosis progression. Clinical Neurophysiology, 185 2111697, 2111697. doi: 10.1016/j.clinph.2026.2111697

Maximal motor unit firing rates decline with amyotrophic lateral sclerosis progression

2026

Journal Article

Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder

Siriratnam, Pakeeran, Jokubaitis, Vilija G., Van Der Walt, Anneke, Sanfilippo, Paul G., Zhu, Chao, Etemadifar, Masoud, Altintas, Ayse, Al-Asmi, Abdullah, Laureys, Guy, Meca-Lallana, Jose E., Foschi, Matteo, Alroughani, Raed, Gomez-Figueroa, Enrique, Habek, Mario, Khoury, Samia J., Simo, Magdolna, Singhal, Bhim Sen G., Jakob, Gregor Brecl, Fabis-Pedrini, Marzena J., Soysal, Aysun, Kermode, Allan G., Shaygannejad, Vahid, Kubala Havrdova, Eva, Millan-Pascual, Jorge, Roos, Izanne, Mccombe, Pamela Ann, Nytrova, Petra, Boz, Cavit, Surcinelli, Andrea ... Fatih Yetkin, Mehmet (2026). Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder. Neurology, 106 (7) e214707. doi: 10.1212/wnl.0000000000214707

Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder

2026

Journal Article

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study

Roos, Izanne, Sharmin, Sifat, Ozakbas, Serkan, Alroughani, Raed, Eichau, Sara, Grand'maison, Francois, Boz, Cavit, Lechner-Scott, Jeannette, Buzzard, Katherine, Prat, Alexandre, Khoury, Samia J., Grammond, Pierre, Van Der Walt, Anneke, Blanco, Yolanda, Foschi, Matteo, Soysal, Aysun, Barnett, Michael, Prevost, Julie, Terzi, Murat, Gerlach, Oliver, Macdonell, Richard, Sa, Maria Jose, Spitaleri, Daniele, Laureys, Guy, Van Pesch, Vincent, John, Nevin, Cartechini, Elisabetta, Gouider, Riadh, Maimone, Davide ... Kalincik, Tomas (2026). Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study. Cns Drugs. doi: 10.1007/s40263-026-01287-8

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study

2026

Journal Article

Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities

Khan, Nemat, Zakriya, Zikra M., McCombe, Pamela and Woodruff, Trent M. (2026). Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities. Trends in Pharmacological Sciences, 47 (4), 355-368. doi: 10.1016/j.tips.2026.02.006

Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities

2026

Journal Article

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis

Hop, Paul J., Kooyman, Maarten, Kenna, Brendan J., Zwamborn, Ramona A. J., van Eijk, Kristel R., Wang, Yan, van Dijk, Charlotte H., Bekema, Erwin, van Rheenen, Wouter, Beele, Paul, van Vugt, Joke J. F. A., Al Khleifat, Ahmad, Iacoangeli, Alfredo, Cooper-Knock, Johnathan, Smith, Bradley N., Topp, Simon, van der Kooi, Anneke J., Fominykh, Vera, Drory, Vivian, Lerner, Yossef, Shovman, Yehuda, Rowe, Dominic B., Williams, Kelly L., McLaughlin, Russell L., Hurt, Jessica, Huang, Yunfeng, Chen, Chia-Yen, Tsai, Ellen, Runz, Heiko ... Veldink, Jan H. (2026). Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis. Nature Genetics, 58 (4), 717-725. doi: 10.1038/s41588-026-02535-9

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis

2026

Journal Article

White matter changes in reward circuits of amyotrophic lateral sclerosis: a fixel-based study of appetite loss

Chang, Jeryn, Lipscombe, Harry, Lv, Jinglei, McCombe, Pamela A., Henderson, Robert D., Ngo, Shyuan T., Steyn, Frederik J. and Shaw, Thomas B. (2026). White matter changes in reward circuits of amyotrophic lateral sclerosis: a fixel-based study of appetite loss. BMC Medicine, 24 (1) 295, 1. doi: 10.1186/s12916-026-04763-6

White matter changes in reward circuits of amyotrophic lateral sclerosis: a fixel-based study of appetite loss

2026

Journal Article

Review of the pathology of muscle in amyotrophic lateral sclerosis

Katz, Matthew, Robertson, Thomas, Ngo, Shyuan T., Yarlagadda, Sai, Henderson, Robert D., McCombe, Pamela A. and Noakes, Peter G. (2026). Review of the pathology of muscle in amyotrophic lateral sclerosis. International Journal of Molecular Sciences, 27 (6) 2802, 1-33. doi: 10.3390/ijms27062802

Review of the pathology of muscle in amyotrophic lateral sclerosis

2026

Journal Article

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis

Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S, Atkins, Harold, Massey, Jennifer, Sutton, Ian, Withers, Barbara, Burman, Joachim, Torkildsen, Øivind, Bø, Lars, Lehmann, Anne Kristine, Havrdova, Eva Kubala, Krasulova, Eva, Trneny, Marek, Kozak, Tomas, Macdonell, Richard, Brown, J William L, Coles, Alasdair, van der Walt, Anneke, Butzkueven, Helmut, Van Wijmeersch, Bart, Lechner-Scott, Jeannette, Barnett, Michael, Laureys, Guy, Willekens, Barbara, Buzzard, Katherine, Skibina, Olga, Di Gregorio, Maria ... Snowden, John A (2026). Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis. Brain, 149 (3), 951-962. doi: 10.1093/brain/awaf286

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis

2026

Conference Publication

Cessation of anti-trafficking therapies after the age of 50 years

Muller, Jannis, Sharmin, Sifat, Buzzard, Katherine, Skibina, Olga, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Mccombe, Pamela, Kermode, Allan, Fabis-Pedrini, Marzena, Macdonell, Richard, Slee, Mark, Garber, Justin, Kuhle, Jens, Kappos, Ludwig, Amato, Maria Pia, Trojan, Maria, Kalincik, Tomas and Roos, Izanne (2026). Cessation of anti-trafficking therapies after the age of 50 years. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Cessation of anti-trafficking therapies after the age of 50 years

2026

Conference Publication

Causal effects of multiple sclerosis therapies in left-truncated registry data

Haile, Dagmawi, Diouf, Ibrahima, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Macdonell, Richard, Barnett, Michael, Shaw, Cameron, Massey, Jennifer, Hardy, Todd A., Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Hodgkinson, Suzanne, Garber, Justin, John, Nevin, Lechner-Scott, Jeannette, Slee, Mark, Kermode, Allan G., Fabis-Pedrini, Marzena, Carroll, William M., McCombe, Pamela, Foong, Yi Chao, Taylor, Bruce, Ferrando, Beatriz Romero, Stuart, Elizabeth, Sharmin, Sifat, Roos, Izanne and Kalincik, Tomas (2026). Causal effects of multiple sclerosis therapies in left-truncated registry data. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Causal effects of multiple sclerosis therapies in left-truncated registry data

2026

Conference Publication

Bayesian networks to generate representative longitudinal data in multiple sclerosis

Qiang, Zhe, Iqbal, Hassam, Sharmina, Sifat, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William, Van Der Walt, Anneke, Butzkueven, Helmut, Lechner-Scott, Jeanette, John, Nevin, Buzzard, Katherine, Skibina, Olga, Barnett, Michael, Mccombe, Pamela, Hodgkinson, Suzanne, Macdonell, Richard, Slee, Mark, Hardy, Todd, Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Taylor, Bruce, Foong, Yi Chao, Garber, Justin, Field, Deborah, Malpas, Charles, Roos, Izanne and Kalincik, Tomas (2026). Bayesian networks to generate representative longitudinal data in multiple sclerosis. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Bayesian networks to generate representative longitudinal data in multiple sclerosis

2026

Conference Publication

Long-term prognostic value of confirmed disability improvements in multiple sclerosis

Lizak, Nathaniel, Sharmin, Sifat, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Barnett, Michael, Kermode, Allan G., Fabis-Pedrini, Marzena, Carroll, William M., John, Nevin, Macdonell, Richard, Hodgkinson, Suzanne, Slee, Mark, McCombe, Pamela, Taylor, Bruce, Garber, Justin, Ferrando, Beatriz Romero, Mason, Deborah, Hardy, Todd, Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Massey, Jennifer, Shaw, Cameron, Field, Deborah, Shuey, Neil, Roos, Izanne and Kalincik, Tomas (2026). Long-term prognostic value of confirmed disability improvements in multiple sclerosis. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Long-term prognostic value of confirmed disability improvements in multiple sclerosis

2026

Conference Publication

Effectiveness of ocrelizumab in multiple sclerosis: a multi-registry cohort study

Roos, Izanne, Sharmin, Sifat, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, Buzzard, Katherine, Lechner-Scott, Jeannette, John, Nevin, Macdonell, Richard, Mccombe, Pamela, Hodgkinson, Suzanne, Kermode, Allan, Vukusic, Sandra, Magyari, Melinda, Laplaud, David and Kalincik, Tomas (2026). Effectiveness of ocrelizumab in multiple sclerosis: a multi-registry cohort study. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Effectiveness of ocrelizumab in multiple sclerosis: a multi-registry cohort study

2026

Conference Publication

Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?

Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Buzzard, Katherine, Horakova, Dana, Havrdova, Eva, Kalincik, Tomas, Roos, Izanne, Hodgkinson, Suzanne, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Ozakbas, Serkan, Surcinelli, Andrea, Foschi, Matteo, Boz, Cavit, Khoury, Samia, Yamout, Bassem, Laureys, Guy, Blanco, Yolanda, Skibina, Olga, Kuhle, Jens, John, Nevin, Alroughani, Raed, Prevost, Julie, Van Pesch, Vincent, Tomassini, Valentina, Prat, Alexandre, Girard, Marc ... Van Der Walt, Anneke (2026). Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?

2026

Conference Publication

Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis

Iqbal, Hassam, Qiang, Zhe, Sharmin, Sifat, Ball, Gareth, Brankovic, Aida, Kermode, Allan G., Fabis-Pedrini, Marzena, Carroll, William M., Buzzard, Katherine, Skibina, Olga, Lechner-Scott, Jeannette, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Barnett, Michael, Hodgkinson, Suzanne, Slee, Mark, Mccombe, Pamela, Taylor, Bruce, Foong, Yi Chao, Macdonell, Richard, Hardy, Todd A., Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Field, Deborah, Massey, Jennifer, Malpas, Charles, Roos, Izanne and Kalincik, Prof Tomas (2026). Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis

2026

Conference Publication

Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset Timing

Sajedi, Seyed Aidin, Zhu, Chao, Abdollahi, Fahimeh, Saberi, Fatemeh, Horakova, Dana, Ozakbas, Serkan, Zakaria, Magd, Shaygannejad, Vahid, Etemadifar, Masoud, Khoury, Samia J., Weinstock-Guttman, Bianca, Patti, Francesco, Boz, Cavit, Eichau, Sara, Tomassini, Valentina, Terzi, Murat, Duquette, Pierre, Kermode, Allan G., Karelis, Guntis, Amato, Maria Pia, Libertinova, Jana, Grand'Maison, Francois, Shalaby, Nevin, Kalincik, Tomas, Buzzard, Katherine, Habek, Mario, Blanco, Yolanda, Grammond, Pierre, Lechner-Scott, Jeannette ... Butzkueven, Helmut (2026). Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset Timing. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset Timing

2026

Conference Publication

Treatment strategies after cell-trafficking agents in MS-patients aged ≥ 50 years

Muller, Jannis, Buzzard, Kathrine, Skibina, Olga, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Mccombe, Pamela, Kermode, Allan G., Fabris-Pedrini, Marzena, Carroll, William M., Macdonell, Richard, Slee, Mark, Kuhle, Jens, Amato, Maria Pia, Trojano, Maria, Kalincik, Tomas and Roos, Izanne (2026). Treatment strategies after cell-trafficking agents in MS-patients aged ≥ 50 years. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Treatment strategies after cell-trafficking agents in MS-patients aged ≥ 50 years